Rift Valley Fever Virus: Propagation, Quantification, and Storage.

Rift Valley fever virus TCID50 bunyaviruses focus-forming assay plaque assay propagation virology virus quantification

Journal

Current protocols in microbiology
ISSN: 1934-8533
Titre abrégé: Curr Protoc Microbiol
Pays: United States
ID NLM: 101257113

Informations de publication

Date de publication:
12 2019
Historique:
entrez: 26 11 2019
pubmed: 26 11 2019
medline: 1 7 2020
Statut: ppublish

Résumé

Rift Valley fever virus (RVFV) is an arthropod-borne, zoonotic disease endemic to sub-Saharan Africa and the Arabian Peninsula. Outbreaks of Rift Valley fever have had up to 100% mortality rates in fetal and neonatal sheep. Upon infection of ruminant and human hosts alike, RVFV infection causes an at times severe hepatitis and pathology in many other organs. The enveloped virion contains a tripartite, predominantly negative-sense, single-stranded RNA genome, which codes for the proteins the virus needs to replicate both in mammalian hosts and insect vectors. Endemic countries often use attenuated RVFV strains for vaccination of livestock but there are no commercially licensed vaccines for humans or livestock in non-endemic areas. In the laboratory, RVFV can be readily propagated and manipulated in vitro using cell culture systems. Presented in this article are techniques routinely used in RVFV research that have proven successful in our laboratories. © 2019 by John Wiley & Sons, Inc. Basic Protocol 1: Propagation of Rift Valley fever virus in mammalian cells Basic Protocol 2: Quantification of Rift Valley fever virus by plaque assay Basic Protocol 3: Quantification of Rift Valley fever virus by 50% tissue culture infectious dose (TCID

Identifiants

pubmed: 31763765
doi: 10.1002/cpmc.92
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e92

Informations de copyright

© 2019 John Wiley & Sons, Inc.

Références

Al-Hazmi, M., Ayoola, E. A., Abdurahman, M., Banzal, S., Ashouraf, J., El-Bushra, A., … Aqeel, A. (2003). Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clinical Infectious Diseases, 36(3), 245-252. doi: 10.1086/345671.
Andrea Capobianco, D., Ortwin, A., Chiara, P., Luigina Di, G., Adrianatus, M., Grazia, B., … Federica, M. (2016). Rift Valley fever virus among wild ruminants, Etosha National Park, Namibia, 2011. Emerging Infectious Disease Journal, 22(1), 128-130. doi: 10.3201/eid2201.150725.
ATCC. (2012). Converting TCID50 to plaque forming units. Retrieved from https://www.atcc.org/en/Global/FAQs/4/8/Converting_TCID50_to_plaque_forming_units_PFU-124.aspx
Baer, A., & Kehn-Hall, K. (2014). Viral concentration determination through plaque assays: Using traditional and novel overlay systems. Journal of Visualized Experiments: JoVE, 93, e52065. doi: 10.3791/52065.
Bird, B. H., Albarino, C. G., Hartman, A. L., Erickson, B. R., Ksiazek, T. G., & Nichol, S. T. (2008). Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. Journal of Virology, 82(6), 2681-2691. doi: 10.1128/JVI.02501-07.
Brackney, D. E., Scott, J. C., Sagawa, F., Woodward, J. E., Miller, N. A., Schilkey, F. D., … Ebel, G. D. (2010). C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLoS Neglected Tropical Diseases, 4(10), e856. doi: 10.1371/journal.pntd.0000856.
Burnett, L. C., Lunn, G., & Coico, R. (2009). Biosafety: Guidelines for working with pathogenic and infectious microorganisms. Current Protocols in Microbiology, 13(1), 1A.1.1-1A.1.14. doi: 10.1002/9780471729259.mc01a01s13.
Chevalier, V., Pépin, M., Plée, L., & Lancelot, R. (2010). Rift Valley fever-a threat for Europe? Euro Surveillance, 15(10), 19506. doi: 10.2807/ese.15.10.19506-en.
Crabtree, M. B., Kent Crockett, R. J., Bird, B. H., Nichol, S. T., Erickson, B. R., Biggerstaff, B. J., … Miller, B. R. (2012). Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: Potential role for NSm in mosquito infection. PLoS Neglected Tropical Diseases, 6(5), e1639. doi: 10.1371/journal.pntd.0001639.
Current Protocols. (2006). Resources for international biosafety guidelines and regulations. Current Protocols in Microbiology, A.1B.1-A.1B.1. doi: 10.1002/9780471729259.mca01bs00.
Daubney, R., & Hudson, J. R. (1931). Enzootic hepatitis or Rift Valley fever. An undescribed virus disease in sheep cattle and man from East Africa. The Journal of Pathology and Bacteriology, 34(2), 545-579. doi: 10.1002/path.1700340418.
de Boer, S. M., Kortekaas, J., de Haan, C. A., Rottier, P. J., Moormann, R. J., & Bosch, B. J. (2012). Heparan sulfate facilitates Rift Valley fever virus entry into the cell. Journal of Virology, 86(24), 13767-13771. doi: 10.1128/JVI.01364-12.
de Boer, S. M., Kortekaas, J., Spel, L., Rottier, P. J., Moormann, R. J., & Bosch, B. J. (2012). Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. Journal of Virology, 86(24), 13642-13652. doi: 10.1128/JVI.01973-12.
Desmyter, J., Melnick, J. L., & Rawls, W. E. (1968). Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). Journal of Virology, 2(10), 955-961.
Filone, C. M., Heise, M., Doms, R. W., & Bertolotti-Ciarlet, A. (2006). Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology, 356(1-2), 155-164. doi: 10.1016/j.virol.2006.07.035.
Gaudreault, N. N., Indran, S. V., Bryant, P. K., Richt, J. A., & Wilson, W. C. (2015). Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines. Frontiers in Microbiology, 6, 664. doi: 10.3389/fmicb.2015.00664.
Ikegami, T., & Makino, S. (2011). The pathogenesis of Rift Valley fever. Viruses, 3(5), 493-519. doi: 10.3390/v3050493.
Ikegami, T., Won, S., Peters, C. J., & Makino, S. (2006). Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. Journal of Virology, 80(6), 2933-2940. doi: 10.1128/JVI.80.6.2933-2940.2006.
Jacobs, J. P., Jones, C. M., & Baille, J. P. (1970). Characteristics of a human diploid cell designated MRC-5. Nature, 227(5254), 168-170. doi: 10.1038/227168a0.
Leger, P., Lara, E., Jagla, B., Sismeiro, O., Mansuroglu, Z., Coppee, J. Y., … Bouloy, M. (2013). Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. Journal of Virology, 87(3), 1631-1648. doi: 10.1128/JVI.02795-12.
Ly, H. J., Lokugamage, N., Nishiyama, S., & Ikegami, T. (2017). Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain. PLoS One, 12(9), e0185194. doi: 10.1371/journal.pone.0185194.
Maringer, K., Yousuf, A., Heesom, K. J., Fan, J., Lee, D., Fernandez-Sesma, A., … Davidson, A. D. (2017). Proteomics informed by transcriptomics for characterising active transposable elements and genome annotation in Aedes aegypti. BMC Genomics, 18(1), 101. doi: 10.1186/s12864-016-3432-5.
Miller, J. R., Koren, S., Dilley, K. A., Puri, V., Brown, D. M., Harkins, D. M., … Shabman, R. S. (2018). Analysis of the Aedes albopictus C6/36 genome provides insight into cell line utility for viral propagation. GigaScience, 7(3), 1-13. doi: 10.1093/gigascience/gix135.
Muller, R., Argentini, C., Bouloy, M., Prehaud, C., & Bishop, D. H. (1991). Completion of the genome sequence of Rift Valley fever phlebovirus indicates that the L RNA is negative sense and codes for a putative transcriptase-replicase [corrected]. Nucleic Acids Research, 19(19), 5433. doi: 10.1093/nar/19.19.5433.
Nishiyama, S., Lokugamage, N., & Ikegami, T. (2016). The L, M, and S Segments of Rift Valley fever virus MP-12 vaccine independently contribute to a temperature-sensitive phenotype. Journal of Virology, 90(7), 3735-3744. doi: 10.1128/JVI.02241-15.
Odendaal, L., Clift, S. J., Fosgate, G. T., & Davis, A. S. (2019). Lesions and cellular tropism of natural Rift Valley fever virus infection in adult sheep. Veterinary Pathology, 56(1), 61-77. doi: 10.1177/0300985818806049.
Osada, N., Kohara, A., Yamaji, T., Hirayama, N., Kasai, F., Sekizuka, T., … Hanada, K. (2014). The genome landscape of the African green monkey kidney-derived vero cell line. DNA Research, 21(6), 673-683. doi: 10.1093/dnares/dsu029.
Phelan, K., & May, M. M. (2015). Basic techniques in mammalian cell tissue culture. Current Protocols in Cell Biology, 66(1), 1.1.1-1.1.22. doi: http://doi.org/10.1002/0471143030.cb0101s66.
Reed, L. J., & Muench, H. (1938). A simple method of estimating fifty percent endpoints. American Journal of Epidemiology, 27(3), 493-497. doi: 10.1093/oxfordjournals.aje.a118408.
Rolin, A. I., Berrang-Ford, L., & Kulkarni, M. A. (2013). The risk of Rift Valley fever virus introduction and establishment in the United States and European Union. Emerging Microbes & Infections, 2(12), e81. doi: 10.1038/emi.2013.81.
Said, A., Elmanzalawy, M., Ma, G., Damiani, A. M., & Osterrieder, N. (2017). An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep. Virology Journal, 14(1), 154. doi: 10.1186/s12985-017-0811-8.
Singh, K. R. P. (1967). Cell cultures derived from larvae of Aedes albopictus (Skuse) and Aedes aegypti (L.). Current Science, 36(9), 506-508.
Weingartl, H. M., Miller, M., Nfon, C., & Wilson, W. C. (2014). Development of a Rift Valley fever virus viremia challenge model in sheep and goats. Vaccine, 32(20), 2337-2344. doi: 10.1016/j.vaccine.2014.02.066.
Weingartl, H. M., Zhang, S., Marszal, P., McGreevy, A., Burton, L., & Wilson, W. C. (2014). Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS One, 9(1), e87385. doi: 10.1371/journal.pone.0087385.
Wilson, W. C., Kim, I. J., Trujillo, J. D., Sunwoo, S. Y., Noronha, L. E., Urbaniak, K., … Richt, J. A. (2018). Susceptibility of white-tailed deer to Rift Valley fever virus. Emerging Infectious Disease Journal, 24(9), 1717-1719. doi: 10.3201/eid2409.180265.

Auteurs

MaRyka R Smith (MR)

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas.

Erin E Schirtzinger (EE)

Arthropod-Borne Animal Diseases Research Unit, Agricultural Research Service, United States Department of Agriculture, Manhattan, Kansas.

William C Wilson (WC)

Arthropod-Borne Animal Diseases Research Unit, Agricultural Research Service, United States Department of Agriculture, Manhattan, Kansas.

A Sally Davis (AS)

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas.

Articles similaires

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4

James Baxter, Ch Julián Villabona-Arenas, Robin N Thompson et al.
1.00
Humans HIV-1 HIV Infections CD4-Positive T-Lymphocytes CD4 Lymphocyte Count
Ultraviolet Rays Disinfection Ultrasonography Surface Properties Humans
SARS-CoV-2 Humans COVID-19 Genome, Viral Polymorphism, Single Nucleotide
Animals Lassa virus Murinae Female Lassa Fever

Classifications MeSH